Partner Therapeutics secures FDA approval for Bizengri
The FDA approval was based on data from the multi-centre, open-label Phase II eNRGy clinical trial.
Drug Development
ACROBiosystems upgrades HEK293 licence solution for R&D compliance
BMS’ Sotyktu secures EC approval for psoriatic arthritis
Construction begins on Novartis’ RLT centre in Texas, US
Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn
Daiichi Sankyo and Waiv partner for ADC biomarkers
Halozyme and Oruka sign agreement for Hypercon technology
Citius raises $36.5m for Lymphir commercialisation
